Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1995 Sep 9;311(7006):655–659. doi: 10.1136/bmj.311.7006.655

Glucose tolerance in patients with cystic fibrosis: five year prospective study.

S Lanng 1, A Hansen 1, B Thorsteinsson 1, J Nerup 1, C Koch 1
PMCID: PMC2551427  PMID: 7549632

Abstract

OBJECTIVES--To study prevalence and incidence of diabetes mellitus in patients with cystic fibrosis. DESIGN--Five year prospective study with annual oral glucose tolerance tests. SETTING--CF Center Copenhagen, Denmark. SUBJECTS--191 patients with cystic fibrosis aged above 2 years. MAIN OUTCOME MEASURES--Glucose tolerance, plasma glucose concentrations after fasting and after glucose loading, and haemoglobin A1c levels. RESULTS--Prevalence of diabetes increased from 11% (n = 21) to 24% (n = 46) during study, with annual age dependent incidence of 4-9%. Diabetes was diagnosed at median age of 21 (range 3-40). At diagnosis of diabetes, symptoms of hyperglycaemia were present in 33% of patients, fasting hyperglycaemia (> or = 7.8 mmol/l) was seen in 16%, and increased haemoglobin A1c levels (> 6.4%) were seen in 16%. Impaired glucose tolerance implied higher risk for development of diabetes than normal glucose tolerance (odds ratio 5.6). In 58% of cases with impaired glucose tolerance, however, glucose tolerance was normal at next annual test. Normal glucose tolerance was found in only 37% of patients at all five tests. Within this group of patients, median plasma glucose concentrations after fasting and after glucose loading and haemoglobin A1c levels increased by 6-8% during study. CONCLUSIONS--Prevalence and incidence of diabetes in cystic fibrosis patients was high and increased with age. Since hyperglycaemic symptoms, fasting hyperglycaemia, and increased levels of glycated haemoglobin did not reliably identify diabetes mellitus, we recommend annual oral glucose tolerance tests in all cystic fibrosis patients aged over 10 years.

Full text

PDF
655

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdul-Karim F. W., Dahms B. B., Velasco M. E., Rodman H. M. Islets of Langerhans in adolescents and adults with cystic fibrosis. A quantitative study. Arch Pathol Lab Med. 1986 Jul;110(7):602–606. [PubMed] [Google Scholar]
  2. Arrigo T., Cucinotta D., Conti Nibali S., Di Cesare E., Di Benedetto A., Magazzù G., De Luca F. Longitudinal evaluation of glucose tolerance and insulin secretion in non-diabetic children and adolescents with cystic fibrosis: results of a two-year follow-up. Acta Paediatr. 1993 Mar;82(3):249–253. doi: 10.1111/j.1651-2227.1993.tb12653.x. [DOI] [PubMed] [Google Scholar]
  3. Artal R., Mosley G. M., Dorey F. J. Glycohemoglobin as a screening test for gestational diabetes. Am J Obstet Gynecol. 1984 Feb 15;148(4):412–414. doi: 10.1016/0002-9378(84)90717-8. [DOI] [PubMed] [Google Scholar]
  4. Banauch D., Brümmer W., Ebeling W., Metz H., Rindfrey H., Lang H., Leybold K., Rick W., Staudinger H. J. Eine Glucose-Dehydrogenase für die Glucose-Bestimmung in Körperflüssigkeiten. Z Klin Chem Klin Biochem. 1975 Mar;13(3):101–107. [PubMed] [Google Scholar]
  5. Bank S., Marks I. N., Vinik A. I. Clinical and hormonal aspects of pancreatic diabetes. Am J Gastroenterol. 1975 Jul;64(1):13–22. [PubMed] [Google Scholar]
  6. Bistritzer T., Sack J., Eshkol A., Katznelson D. Hemoglobin A1 and pancreatic beta cell function in cystic fibrosis. Isr J Med Sci. 1983 Jul;19(7):600–603. [PubMed] [Google Scholar]
  7. Elborn J. S., Shale D. J., Britton J. R. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax. 1991 Dec;46(12):881–885. doi: 10.1136/thx.46.12.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Finkelstein S. M., Wielinski C. L., Elliott G. R., Warwick W. J., Barbosa J., Wu S. C., Klein D. J. Diabetes mellitus associated with cystic fibrosis. J Pediatr. 1988 Mar;112(3):373–377. doi: 10.1016/s0022-3476(88)80315-9. [DOI] [PubMed] [Google Scholar]
  9. GIBSON L. E., COOKE R. E. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959 Mar;23(3):545–549. [PubMed] [Google Scholar]
  10. Handwerger S., Roth J., Gorden P., Di Sant' Agnese P., Carpenter D. F., Peter G. Glucose intolerance in cystic fibrosis. N Engl J Med. 1969 Aug 28;281(9):451–461. doi: 10.1056/NEJM196908282810901. [DOI] [PubMed] [Google Scholar]
  11. Iannucci A., Mukai K., Johnson D., Burke B. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol. 1984 Mar;15(3):278–284. doi: 10.1016/s0046-8177(84)80191-4. [DOI] [PubMed] [Google Scholar]
  12. Lanng S., Schwartz M., Thorsteinsson B., Koch C. Endocrine and exocrine pancreatic function and the delta F508 mutation in cystic fibrosis. Clin Genet. 1991 Nov;40(5):345–348. doi: 10.1111/j.1399-0004.1991.tb03107.x. [DOI] [PubMed] [Google Scholar]
  13. Lanng S., Thorsteinsson B., Erichsen G., Nerup J., Koch C. Glucose tolerance in cystic fibrosis. Arch Dis Child. 1991 May;66(5):612–616. doi: 10.1136/adc.66.5.612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lanng S., Thorsteinsson B., Lund-Andersen C., Nerup J., Schiøtz P. O., Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr. 1994 Jan;83(1):72–77. doi: 10.1111/j.1651-2227.1994.tb12956.x. [DOI] [PubMed] [Google Scholar]
  15. Lanng S., Thorsteinsson B., Nerup J., Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr. 1994 Aug;83(8):849–853. doi: 10.1111/j.1651-2227.1994.tb13156.x. [DOI] [PubMed] [Google Scholar]
  16. Lanng S., Thorsteinsson B., Nerup J., Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr. 1992 Sep;151(9):684–687. doi: 10.1007/BF01957574. [DOI] [PubMed] [Google Scholar]
  17. Lanng S., Thorsteinsson B., Pociot F., Marshall M. O., Madsen H. O., Schwartz M., Nerup J., Koch C. Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatr. 1993 Feb;82(2):150–154. doi: 10.1111/j.1651-2227.1993.tb12628.x. [DOI] [PubMed] [Google Scholar]
  18. Lanng S., Thorsteinsson B., Røder M. E., Orskov C., Holst J. J., Nerup J., Koch C. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol (Copenh) 1993 Mar;128(3):207–214. doi: 10.1530/acta.0.1280207. [DOI] [PubMed] [Google Scholar]
  19. Little R. R., England J. D., Wiedmeyer H. M., Madsen R. W., Pettitt D. J., Knowler W. C., Goldstein D. E. Glycated haemoglobin predicts progression to diabetes mellitus in Pima Indians with impaired glucose tolerance. Diabetologia. 1994 Mar;37(3):252–256. doi: 10.1007/BF00398051. [DOI] [PubMed] [Google Scholar]
  20. Moran A., Diem P., Klein D. J., Levitt M. D., Robertson R. P. Pancreatic endocrine function in cystic fibrosis. J Pediatr. 1991 May;118(5):715–723. doi: 10.1016/s0022-3476(05)80032-0. [DOI] [PubMed] [Google Scholar]
  21. Nielsen O. H., Flensborg E. W. Svedelektrolytundersøgelse med pilokarpin-iontoforesemetoden. Ugeskr Laeger. 1981 Aug 31;143(36):2302–2306. [PubMed] [Google Scholar]
  22. Reisman J., Corey M., Canny G., Levison H. Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics. 1990 Sep;86(3):374–377. [PubMed] [Google Scholar]
  23. Robert J. J., Grasset E., de Montalembert M., Chevenne D., Deschamps I., Boitard C., Lenoir G. Recherche de facteurs d'intolérance au glucose dans la mucoviscidose. Arch Fr Pediatr. 1992 Jan;49(1):17–22. [PubMed] [Google Scholar]
  24. Rodman H. M., Doershuk C. F., Roland J. M. The interaction of 2 diseases: diabetes mellitus and cystic fibrosis. Medicine (Baltimore) 1986 Nov;65(6):389–397. doi: 10.1097/00005792-198611000-00004. [DOI] [PubMed] [Google Scholar]
  25. Schwartz M., Johansen H. K., Koch C., Brandt N. J. Frequency of the delta F508 mutation on cystic fibrosis chromosomes in Denmark. Hum Genet. 1990 Sep;85(4):427–428. doi: 10.1007/BF02428297. [DOI] [PubMed] [Google Scholar]
  26. Soejima K., Landing B. H. Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: morphometric and immunocytologic studies. Pediatr Pathol. 1986;6(1):25–46. doi: 10.3109/15513818609025923. [DOI] [PubMed] [Google Scholar]
  27. Stutchfield P. R., O'Halloran S., Teale J. D., Isherwood D., Smith C. S., Heaf D. Glycosylated haemoglobin and glucose intolerance in cystic fibrosis. Arch Dis Child. 1987 Aug;62(8):805–810. doi: 10.1136/adc.62.8.805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Svendsen P. A., Lauritzen T., Søegaard U., Nerup J. Glycosylated haemoglobin and steady-state mean blood glucose concentration in Type 1 (insulin-dependent) diabetes. Diabetologia. 1982 Nov;23(5):403–405. doi: 10.1007/BF00260951. [DOI] [PubMed] [Google Scholar]
  29. Trezise A. E., Buchwald M. In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator. Nature. 1991 Oct 3;353(6343):434–437. doi: 10.1038/353434a0. [DOI] [PubMed] [Google Scholar]
  30. Yudkin J. S., Alberti K. G., McLarty D. G., Swai A. B. Impaired glucose tolerance. BMJ. 1990 Sep 1;301(6749):397–402. doi: 10.1136/bmj.301.6749.397. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES